drug
as of 2026-07-01Citalopram
MeSH D015283
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Hannover Medical School
5 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
5
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia
NCT01032083Phase 4Completed
DECIFER: Depression and Citalopram In First Episode Recovery
NCT01041274Phase 4Completed
Effect of Add-on Citalopram to Risperidone on Negative Symptoms in Schizophrenia
NCT00893256Phase 4Completed
CATIE-Alzheimer's Disease Trial
NCT00015548—Completed
KOLs & investigators
6
Donald C. Goff, MDKOL score 8
Helge Frieling, Prof., MDKOL score 5
John W. Newcomer, M.D.KOL score 5
Pierre Tariot, MDKOL score 2
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
indication
KOL
Donald C. Goff, MD
personKOL score 8
Helge Frieling, Prof., MD
personKOL score 5
John W. Newcomer, M.D.
personKOL score 5
Pierre Tariot, MD
personKOL score 2